The Natural History of Pediatric Ulcerative Colitis: A Population-Based Cohort Study

被引:249
作者
Gower-Rousseau, Corinne [2 ]
Dauchet, Luc [2 ]
Vernier-Massouille, Gwenola [1 ]
Tilloy, Emmanuelle [2 ]
Brazier, Franck [3 ]
Merle, Veronique [4 ]
Dupas, Jean-Louis [3 ]
Savoye, Guillaume [4 ]
Balde, Mamadou [2 ]
Marti, Raymond [5 ]
Lerebours, Eric [4 ]
Cortot, Antoine [1 ]
Salomez, Jean-Louis [2 ]
Turck, Dominique [6 ]
Colombel, Jean-Frederic [1 ]
机构
[1] CHRU Lille, EPIMAD, Serv Hepatogastroenterol, Lille, France
[2] Univ Lille 2, Registre Malad Inflammatoires Chron Intestin Nord, EPIMAD, Pole Sante Publ CHRU,EA2694, F-59800 Lille, France
[3] CHRU Amiens, EPIMAD, Ctr Amiens, Hop Nord, Amiens, France
[4] CHRU Rouen, EPIMAD, Ctr Rouen, Hop Charles Nicolle, Rouen, France
[5] Ctr Hosp Gen, EPIMAD, Serv Hepatogastroenterol, Calais, France
[6] CHRU Lille, EPIMAD, Serv Pediat, Hop Jeanne dep Flandre, Lille, France
关键词
INFLAMMATORY-BOWEL-DISEASE; CLINICAL-FEATURES; CROHNS-DISEASE; FOLLOW-UP; CORTICOSTEROID-THERAPY; SCOTTISH CHILDREN; CHILDHOOD; ONSET; ASSOCIATION; AZATHIOPRINE;
D O I
10.1038/ajg.2009.177
中图分类号
R57 [消化系及腹部疾病];
学科分类号
100201 [内科学];
摘要
OBJECTIVES: The natural history of ulcerative colitis (UC) has been poorly described in children. METHODS: In a geographically derived incidence cohort diagnosed from 1988 to 2002, we identified 113 UC patients (age 0-17 years at diagnosis) with a follow-up of at least 2 years. The cumulative risk of colectomy was estimated by the Kaplan-Meier method. Risk factors for disease extension were assessed with logistic regression models, and risk factors for colectomy with Cox hazards proportional models. RESULTS: Median follow-up time was 77 months (46-125). At diagnosis, 28% of patients had proctitis, 35% left-sided colitis, and 37% extensive colitis. Disease course was characterized by disease extension in 49% of patients. A delay in diagnosis of more than 6 months and a family history of inflammatory bowel disease were associated with an increased risk of disease extension, with odds ratios of 5.0 (1.2-21.5) and 11.8 (1.3-111.3), respectively. The cumulative rate of colectomy was 8% at 1 year, 15% at 3 years, and 20% at 5 years. The presence of extra-intestinal manifestations (EIMS) at diagnosis was associated with an increased risk of colectomy (hazard ratio (HR) = 3.5 (1.2-10.5)). Among the patients with limited disease at diagnosis, the risk of colectomy was higher in those who experienced disease extension than in those who did not (HR = 13.3 1.7-101.7). CONCLUSIONS: Pediatric UC was characterized by widespread localization at diagnosis and a high rate of disease extension. Twenty percent of children had their colon removed after 5 years. The colectomy rate was influenced by disease extension and was associated with the presence of EIMS at diagnosis.
引用
收藏
页码:2080 / 2088
页数:9
相关论文
共 48 条
[1]
Clinical relevance of advances in genetics and pharmacogenetics of IBD [J].
Ahmad, T ;
Tamboli, CP ;
Jewell, D ;
Colombel, JF .
GASTROENTEROLOGY, 2004, 126 (06) :1533-1549
[2]
Incidence of juvenile-onset Crohn's disease in Scotland: Association with northern latitude and affluence [J].
Armitage, EL ;
Aldhous, MC ;
Anderson, N ;
Drummond, HE ;
Riemersma, RA ;
Ghosh, S ;
Satsangi, J .
GASTROENTEROLOGY, 2004, 127 (04) :1051-1057
[3]
Incidence, clinical presentation and location at diagnosis of pediatric inflammatory bowel disease:: A prospective population-based study in northern France (1988-1999) [J].
Auvin, S ;
Molinié, T ;
Gower-Rousseau, T ;
Brazier, F ;
Merle, V ;
Grandbastien, B ;
Marti, R ;
Lerebours, I ;
Dupas, JTL ;
Colombel, JF ;
Salomez, JL ;
Cortot, A ;
Turck, D .
JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 2005, 41 (01) :49-55
[4]
BARTON JR, 1990, Q J MED, V75, P423
[5]
INCIDENCE OF INFLAMMATORY BOWEL-DISEASE IN SCOTTISH CHILDREN BETWEEN 1968 AND 1983 - MARGINAL FALL IN ULCERATIVE-COLITIS, 3-FOLD RISE IN CROHNS-DISEASE [J].
BARTON, JR ;
GILLON, S ;
FERGUSON, A .
GUT, 1989, 30 (05) :618-622
[6]
Gastroenterology 2 - Inflammatory bowel disease: clinical aspects and established and evolving therapies [J].
Baumgart, Daniel C. ;
Sandborn, William J. .
LANCET, 2007, 369 (9573) :1641-1657
[7]
European evidence-based Consensus on the management of ulcerative colitis: Special situations (Publication with Expression of Concern) [J].
Biancone, Livia ;
Michetti, Pierre ;
Travis, Simon ;
Escher, Johanna C. ;
Moser, Gabriele ;
Forbes, Alastair ;
Hoffmann, Joerg C. ;
Dignass, Axel ;
Gionchetti, Paolo ;
Jantschek, Guenter ;
Kiesslich, Ralf ;
Kolacek, Sanja ;
Mitchell, Rod ;
Panes, Julian ;
Soderholm, Johan ;
Vucelic, Boris ;
Stange, Eduard .
JOURNAL OF CROHNS & COLITIS, 2008, 2 (01) :63-92
[8]
Association of the interleukin 1 receptor antagonist gene with ulcerative colitis in Northern European Caucasians [J].
Carter, MJ ;
di Giovine, FS ;
Jones, S ;
Mee, J ;
Camp, NJ ;
Lobo, AJ ;
Duff, GW .
GUT, 2001, 48 (04) :461-467
[9]
The epidemiology of paediatric inflammatory bowel disease [J].
Cosgrove, M ;
AlAtia, RF ;
Jenkins, HR .
ARCHIVES OF DISEASE IN CHILDHOOD, 1996, 74 (05) :460-461
[10]
CLINICAL-PATTERNS, NATURAL-HISTORY, AND PROGRESSION OF ULCERATIVE-COLITIS - A LONG-TERM FOLLOW-UP OF 1116 PATIENTS [J].
FARMER, RG ;
EASLEY, KA ;
RANKIN, GB .
DIGESTIVE DISEASES AND SCIENCES, 1993, 38 (06) :1137-1146